Roughly 80% of doctors are concerned about how they will be treated when they grow old and fear that present guidelines to deal with the ageing population are not “comprehensive, realistic or sufficiently funded to address future demand”. That is one of the main findings of a recent study from the Economist Intelligence Unit (EIU),
UK Health Secretary, Andrew Lansley, has announced that one-year pilot schemes for a new initiative which allow patients to choose their GP practice will start in April this year. The trials, which will run in parts of central London, Manchester/Salford and Nottingham, will allow the public, for the first time, to select whether they want
The EU’s (European Union) proposal for a new directive on public procurement will permit “more scope for negotiating with suppliers,” according to the NHS Confederation. The plans, which have been published by the European Commission this week, contain a number of provisions intended to simplify the rules for the purchasing goods and services, and making
The multiple myeloma drug therapy market will experience robust growth averaging 5.6% annually from 2010 to 2020 in seven of the world’s major markets, according to new projections. Growth in these markets – US, Italy, Spain, UK, France, Germany and Japan – will be driven by additional penetration of Celgene’s Revlimid (lenalidomide) into the first-line
We would like to wish all of Only Medics’ clients and candidates a very Merry Christmas and Best Wishes for the New Year. Thank you for your business in 2011 and we look forward to working with you in 2012! Please note the following office hours: Only Medics will be closed from midday on Friday,
The NHS is to gain a funding boost of over £2.5 billion to deliver services to patients in 2012-13, Health Secretary Andrew Lansley has announced. £91.6 billion will be given to Primary Care Trusts, representing a 2.8% rise in total allocations. The funding breaks down as follows: £87.5 billion for Primary Care Trusts to provide care
Galapagos of Belgium yesterday announced that they have reached milestones in its osteoarthritis alliance with Servier, resulting in a payment of 4 million euros from the French drugmaker. In July 2010, teamed up for a collaboration that could be worth around 300 million euros to the Mechelen-based group, which is responsible for the discovery and
Ratings agency Fitch has issued a report predicting that the pharmaceutical sector will “continue to experience significant operating challenges” in 2012 but while issuing a negative outlook, they added that pharmaceuticals will still be one of the highest-rated industries. The new analysis comments that the 15 global pharmaceutical companies covered by the report will suffer
The National Lung Cancer Audit announced that the proportion of patients receiving key care measures, such as surgery or anti-cancer treatment like chemotherapy or radiotherapy, is improving each year. 58.4% of patients with lung cancer in England and Wales and 63.9% in Scotland received an anti-cancer treatment in 2010, compared to 54% and 64.1% respectively
A small trial which shows that symptoms improved considerably in adults with the bleeding disorder haemophilia B, after a single treatment with gene therapy, has caused excitement among the scientific community. A single treatment with gene therapy developed by researchers at St Jude Children’s Research Hospital in Memphis, USA has been proven to be safe
